Preparation method of brain peptide for preventing Alzheimer's disease

By using the MRM molecular resonance environment and the synergistic effect of trypsin and chymotrypsin during the brain peptide extraction process, the problems of low extraction efficiency and difficult to guarantee purity are solved, and efficient brain peptide extraction is achieved, with the extraction rate reaching no less than 4.25%.

CN118726526BActive Publication Date: 2024-11-26DEZHOU LANLI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411216716.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-11-26
Estimated Expiration
2044-09-02

AI Technical Summary

Technical Problem

The prior art is difficult to ensure the purity and low extraction efficiency when extracting brain peptides, resulting in an impact on yield.

Method used

The salting reaction and enzymatic lysis process were carried out using the MRM molecular resonance environment to increase the amount of negative ions, and trypsin and chymotrypsin worked together to improve the degree of hydrolysis reaction of brain tissue proteins.

Benefits of technology

The extraction efficiency and purity of brain peptides have been significantly improved, and efficient brain peptide extraction has been achieved, and the extraction rate has been increased to no less than 4.25%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

The present invention proposes a method for preparing a brain peptide for preventing Alzheimer's disease, which relates to the technical field of peptide extraction. The brain peptide for preventing Alzheimer's disease is prepared by cold grinding and acid removal, molecular resonance-assisted salting out, molecular resonance-assisted enzymatic hydrolysis, secondary enzymatic hydrolysis, and ultrafiltration drying. The technical solution provided by the present invention adopts an MRM molecular resonance environment to increase the amount of negative ions generated during the salting out reaction and the primary enzymatic hydrolysis process, accelerate the reaction process, promote the improvement of the protein extraction rate, and promote enzymatic hydrolysis to improve the extraction rate of brain peptides, thereby improving the extraction efficiency of brain peptides; by using trypsin and chymotrypsin in synergistic use, the degree of hydrolysis reaction of brain tissue protein is increased, and the extraction rate of brain peptides is further improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of peptide extraction, and in particular to a method for preparing a brain peptide for preventing Alzheimer's disease. Background Art

[0002] Brain peptides are a variety of small molecule peptides present in the brain. These small molecule peptides have important medicinal value, such as antibacterial, anti-inflammatory, and antioxidant effects. They are very helpful for problems such as Alzheimer's disease, memory loss, and inattention.

[0003] At present, some progress has been made in extracting brain peptides, but there are still some technical bottlenecks:

[0004] (1) Purity is difficult to guarantee: Since brain tissue contains multiple components, the extracted small molecule peptides are often accompanied by other impurities, making it difficult to achieve purity requirements;

[0005] (2) Low extraction efficiency: Some small molecule peptides may be tightly bound to other components in the tissue, resulting in low extraction efficiency and affecting the yield. Summary of the invention

[0006] The main purpose of the present invention is to provide a method for preparing a brain peptide for preventing Alzheimer's disease, aiming to improve the extraction purity and extraction efficiency of the brain peptide.

[0007] To achieve the above object, the present invention provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0008] S10. Use animal brain tissue as raw material, grind it at 0-4℃, refrigerate it for 12 h-24 h, drain the acid, wash it, and freeze-dry it to obtain brain tissue powder;

[0009] S20. mixing the brain tissue powder with the NaCl solution and then soaking it in an MRM molecular resonance environment to cause a salting-out reaction, and centrifuging and filtering it. The filter residue is the brain tissue protein, and the filtrate is the brain tissue peptide solution;

[0010] S30. Suspend brain tissue protein in phosphate buffer, add papain and bromelain, and generate negative ions at 2000 e - / cm 3 ~2500 e - / cm 3 Under the MRM molecular resonance environment, the reaction was carried out in a water bath at 50℃~60℃ for 60 min~90 min, the enzyme was inactivated, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate;

[0011] S40. Mix the brain tissue peptide solution, brain tissue protease hydrolysate and weak alkaline buffer, add trypsin and chymotrypsin, react in a water bath at 37℃~40℃ for 60 min~90 min, inactivate the enzyme, cool, ultrafilter and spray-dry the filtrate to obtain brain peptides for preventing Alzheimer's disease.

[0012] In one embodiment, in step S10, a Tris-HCl buffer is used for washing, and the pH value of the Tris-HCl buffer is 7.5-8.5.

[0013] In one embodiment, in step S20, the mass proportion of NaCl in the NaCl solution is 2% to 4%;

[0014] The mass concentration of the brain tissue powder in the NaCl solution is 50-70 g / L.

[0015] In one embodiment, in step S30, the pH value of the phosphate buffer is 6.5-7.5.

[0016] In one embodiment, in step S30, the mass concentration of papain in the phosphate buffer is 40-60 g / L, and the mass concentration of bromelain in the phosphate buffer is 40-60 g / L.

[0017] In one embodiment, in step S40, the weak alkaline buffer comprises a Tris-HCl buffer, and the pH value of the Tris-HCl buffer is 7.5-8.5.

[0018] In one embodiment, in step S40, the volume ratio of the brain tissue peptide solution, the brain tissue protease hydrolysate and the buffer solution is 1:1:(1-2).

[0019] In one embodiment, in step S30, the step of inactivating the enzyme comprises a boiling water bath for 10 to 15 minutes; and / or,

[0020] In step S40, the step of inactivating the enzyme includes boiling water bath for 10 to 15 minutes.

[0021] In one embodiment, in step S40, the ultrafiltration step uses a 4.5 kDa ultrafiltration membrane to perform centrifugal filtration rate separation.

[0022] In one embodiment, in step S40, the step of concentrating and drying comprises vacuum freeze drying.

[0023] The technical solution provided by the present invention adopts the MRM molecular resonance environment to increase the amount of negative ions generated in the salting-out reaction and the primary enzymatic hydrolysis process, accelerate the reaction process, promote the improvement of protein extraction rate, and promote enzymatic hydrolysis to improve the extraction rate of brain peptides, thereby improving the extraction efficiency of brain peptides; by using trypsin and chymotrypsin in combination, the degree of hydrolysis reaction of brain tissue protein is increased, and the extraction rate of brain peptides is further improved. DETAILED DESCRIPTION

[0024] To make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them.

[0025] It should be noted that, in the embodiments, those without specifying specific conditions are carried out according to normal conditions or conditions recommended by the manufacturer. Those without specifying the manufacturer of reagents or instruments used are conventional products that can be purchased commercially. In addition, the meaning of "and / or" appearing in the full text includes three parallel schemes, and "A and / or B" is taken as an example, including schemes A, B, or A and B that meet the same time. In addition, the technical schemes between the various embodiments can be combined with each other, but must be based on the ability of ordinary technicians in the field to achieve. When the combination of the technical schemes is contradictory or cannot be achieved, it should be considered that the combination of such technical schemes does not exist, and is not within the scope of protection required by the present invention. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in the field without making creative work, all belong to the scope of protection of the present invention.

[0026] At present, some progress has been made in extracting brain peptides, but there are still some technical bottlenecks:

[0027] (1) Purity is difficult to guarantee: Since brain tissue contains multiple components, the extracted small molecule peptides are often accompanied by other impurities, making it difficult to achieve purity requirements;

[0028] (2) Low extraction efficiency: Some small molecule peptides may be tightly bound to other components in the tissue, resulting in low extraction efficiency and affecting the yield.

[0029] In view of this, the present invention proposes a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0030] S10. Use animal brain tissue as raw material, grind it at 0-4℃, refrigerate it for 12 h-24 h, drain the acid, wash it, and freeze-dry it to obtain brain tissue powder;

[0031] S20. mixing the brain tissue powder with the NaCl solution and then soaking it in an MRM molecular resonance environment to cause a salting-out reaction, and centrifuging and filtering it. The filter residue is the brain tissue protein, and the filtrate is the brain tissue peptide solution;

[0032] S30. Suspend brain tissue protein in phosphate buffer, add papain and bromelain, and generate negative ions at 2000 e - / cm 3 ~2500 e - / cm 3 Under the MRM molecular resonance environment, the reaction was carried out in a water bath at 50℃~60℃ for 60 min~90 min, the enzyme was inactivated, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate;

[0033] S40. Mix the brain tissue peptide solution, brain tissue protease hydrolysate and weak alkaline buffer, add trypsin and chymotrypsin, react in a water bath at 37℃~40℃ for 60 min~90 min, inactivate the enzyme, cool, ultrafilter and spray-dry the filtrate to obtain brain peptides for preventing Alzheimer's disease.

[0034] The technical solution provided by the present invention adopts the MRM molecular resonance environment to increase the amount of negative ions generated in the salting-out reaction and the primary enzymatic hydrolysis process, accelerate the reaction process, promote the improvement of protein extraction rate, and promote enzymatic hydrolysis to improve the extraction rate of brain peptides, thereby improving the extraction efficiency of brain peptides; by adopting the synergistic use of trypsin and chymotrypsin, the degree of hydrolysis reaction of brain tissue protein is increased, and the extraction rate of brain peptides is further improved.

[0035] The brain peptides prepared by the preparation method of the present scheme include small molecule peptides such as neuropeptides, cerebroside carnosine and collagen peptides; among them, neuropeptides are endogenous active substances existing in nerve tissue and participating in the function of the nervous system. Animal experiments show that certain specific acidic peptides can significantly improve cognitive dysfunction and learning and memory impairment caused by Alzheimer's disease, and have the potential to prevent and treat Alzheimer's disease; cerebroside carnosine can repair damaged nerves, has the functions of protecting brain nerves, nourishing brain nerves and promoting brain nerve regeneration, and is often used in the treatment of nerve damage and Alzheimer's disease caused by cerebral thrombosis, and also shows a certain preventive value; collagen peptides have little to do with the main role of preventing Alzheimer's disease, but collagen peptides may indirectly benefit brain health by improving the overall health of the body, thereby indirectly preventing Alzheimer's disease.

[0036] In one embodiment, in step S10, a Tris-HCl buffer is used for washing, and the pH value of the Tris-HCl buffer is 7.5-8.5.

[0037] In one embodiment, in step S20, the mass proportion of NaCl in the NaCl solution is 2%-4%; and the mass concentration of the brain tissue powder in the NaCl solution is 50-70 g / L.

[0038] In one embodiment, in step S30, the pH value of the phosphate buffer is 6.5-7.5.

[0039] In one embodiment, in step S30, the mass concentration of papain in the phosphate buffer is 40-60 g / L, and the mass concentration of bromelain in the phosphate buffer is 40-60 g / L.

[0040] In one embodiment, in step S40, the weak alkaline buffer comprises a Tris-HCl buffer, and the pH value of the Tris-HCl buffer is 7.5-8.5.

[0041] In one embodiment, in step S40, the volume ratio of the brain tissue peptide solution, the brain tissue protease hydrolysate and the buffer solution is 1:1:(1-2).

[0042] In one embodiment, in step S30, the step of inactivating the enzyme comprises boiling water bath for 10 to 15 min; and / or, in step S40, the step of inactivating the enzyme comprises boiling water bath for 10 to 15 min.

[0043] In one embodiment, in step S40, the ultrafiltration step uses a 4.5 kDa ultrafiltration membrane to perform centrifugal filtration rate separation.

[0044] In one embodiment, in step S40, the step of concentrating and drying comprises vacuum freeze drying.

[0045] The technical solution of the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only used to explain the present invention, and are not used to limit the present invention.

[0046] Example 1

[0047] This embodiment provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0048] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0049] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a chamber with an anion generation rate of 2500 e - / cm 3The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0050] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, and add 2500 e-ion. - / cm 3 The reaction was carried out in a 55°C water bath for 70 min under the MRM molecular resonance environment, and the enzyme was inactivated in a boiling water bath for 10 min. The reaction was then cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate.

[0051] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.8 g of trypsin and 0.8 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme in a boiling water bath for 10 min, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0052] Example 2

[0053] This embodiment provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0054] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0055] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a chamber with an anion generation rate of 2000 e - / cm 3 The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0056] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.4 g papain and 0.4 g bromelain, and add 2000 e-ion generation. - / cm 3 The reaction was carried out in a 50℃ water bath for 60 min under the MRM molecular resonance environment, and the enzyme was inactivated in a boiling water bath for 10 min. The reaction was then cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate.

[0057] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.6 g of trypsin and 0.6 g of chymotrypsin, react in a 37°C water bath for 60 min, inactivate the enzyme in a boiling water bath for 10 min, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0058] Example 3

[0059] This embodiment provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0060] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 0°C, refrigerated for 12 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0061] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a - / cm 3 The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0062] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.6 g papain and 0.6 g bromelain, and add 2200 e-ion generation. - / cm 3 The reaction was carried out in a 60°C water bath for 70 min on the MRM molecular resonance plate, and the enzyme was inactivated in a boiling water bath for 15 min. The reaction was then cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate.

[0063] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 20 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.9 g of trypsin and 0.9 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme in a boiling water bath for 15 min, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0064] Example 4

[0065] This embodiment provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0066] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 4°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0067] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a - / cm 3 The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0068] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, and add 2300 e-ion. - / cm 3 The reaction was carried out in a 55°C water bath on the MRM molecular resonance plate for 70 min, the enzyme was inactivated in a boiling water bath for 10 min, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate;

[0069] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 15 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.8 g of trypsin and 0.8 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme in a boiling water bath for 10 min, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0070] Example 5

[0071] This embodiment provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0072] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0073] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a chamber with an anion generation rate of 2500 e - / cm 3 The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0074] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, and add 2500 e-ion. - / cm 3 The reaction was carried out in a 55°C water bath on the MRM molecular resonance plate for 70 min, the enzyme was inactivated in a boiling water bath for 10 min, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate;

[0075] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.8 g of trypsin and 0.8 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme in a boiling water bath for 10 min, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0076] Comparative Example 1

[0077] This comparative example provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0078] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0079] S20. Mix the brain tissue powder with 10 mL of 3% (w / w) NaCl solution and soak for 4 h to cause salting out reaction. Centrifuge and filter. The residue is brain tissue protein and the filtrate is brain tissue peptide solution.

[0080] S30. Suspend the brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, react in a 55°C water bath for 70 min, inactivate the enzyme, cool, centrifuge, collect the supernatant, and obtain the brain tissue protease hydrolysate;

[0081] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.8 g of trypsin and 0.8 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0082] Comparative Example 2

[0083] This comparative example provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0084] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0085] S20. Mix the brain tissue powder with 10 mL of 3% (w / w) NaCl solution and soak for 4 h to cause salting out reaction. Centrifuge and filter. The residue is brain tissue protein and the filtrate is brain tissue peptide solution.

[0086] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, and add 2500 e-ion. - / cm 3 The reaction was carried out in a 55°C water bath on the MRM molecular resonance plate for 70 min, the enzyme was inactivated, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate;

[0087] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.8 g of trypsin and 0.8 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, spray dry, and obtain brain tissue enzymatic hydrolysate dry powder, which is the brain peptide for preventing Alzheimer's disease.

[0088] Comparative Example 3

[0089] This comparative example provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0090] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0091] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a chamber with an anion generation rate of 2500 e - / cm 3 The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0092] S30. Suspend the brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, react in a 55°C water bath for 70 min, inactivate the enzyme, cool, centrifuge, collect the supernatant, and obtain the brain tissue protease hydrolysate;

[0093] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 0.8 g of trypsin and 0.8 g of chymotrypsin, react in a 37°C water bath for 90 min, inactivate the enzyme, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, spray dry, and obtain brain tissue enzymatic hydrolysate dry powder, which is the brain peptide for preventing Alzheimer's disease.

[0094] Comparative Example 4

[0095] This comparative example provides a method for preparing a brain peptide for preventing Alzheimer's disease, comprising the following steps:

[0096] S10. 50 g of fresh bovine brain tissue was used as raw material, ground at 2°C, refrigerated for 24 h to remove the acid, washed with Tris-HCl buffer (50 mM, pH 8.0), and freeze-dried to obtain brain tissue powder;

[0097] S20. Mix brain tissue powder with 10 mL of 3% (w / w) NaCl solution and place in a chamber with an anion generation rate of 2500 e - / cm 3 The MRM molecular resonance plate was soaked for 4 h to cause salting out reaction, and then centrifuged and filtered. The residue was brain tissue protein, and the filtrate was brain tissue peptide solution.

[0098] S30. Suspend brain tissue protein in 10 mL phosphate buffer (50 mM, pH 7.0), add 0.5 g papain and 0.5 g bromelain, and add 2500 e-ion. - / cm 3 The reaction was carried out in a 55°C water bath on the MRM molecular resonance plate for 70 min, the enzyme was inactivated in a boiling water bath for 10 min, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate;

[0099] S40. Mix 10 mL of brain tissue peptide solution, 10 mL of brain tissue protease hydrolysate and 10 mL of Tris-HCl buffer (50 mM, pH 8.0), add 1.6 g of trypsin, react in a 37°C water bath for 90 min, inactivate the enzyme in a boiling water bath for 10 min, cool, and use a 4.5 kDa ultrafiltration membrane for centrifugal filtration separation to obtain an ultrafiltrate less than 4.5 kDa, and spray dry to obtain brain peptides for preventing Alzheimer's disease.

[0100] Performance Testing

[0101] The extraction rates of the brain peptides for preventing Alzheimer's disease prepared in Examples 1 to 5, Comparative Examples 1 and 2 were measured. The results are shown in Table 1. Extraction rate = mass of peptide / mass of protein.

[0102] Table 1 Extraction rate results

[0103]

[0104] According to the results in Table 1, it can be seen that Examples 1 to 5 use the MRM molecular resonance environment to increase the amount of negative ions generated during the salting-out reaction and the primary enzymatic hydrolysis process, accelerate the reaction process, promote the improvement of protein extraction rate, and promote enzymatic hydrolysis to increase the extraction rate of brain peptides. The extraction rates of Examples 1 to 5 are not less than 4.25%.

[0105] Comparative Examples 1 to 3 did not use the MRM molecular resonance environment throughout the salting-out reaction and the primary enzymatic hydrolysis process, resulting in slow reaction rates in the salting-out reaction or the primary enzymatic hydrolysis process and incomplete reactions. Therefore, the extraction rates of Comparative Examples 1 to 3 were all no higher than 3.53%.

[0106] In Comparative Example 4, only trypsin was used to hydrolyze brain tissue protein, but no trypsin was used. The hydrolysis degree of brain tissue protein was low, resulting in a decrease in the content of brain peptides. The extraction rate of brain peptides was 3.73%.

[0107] The above description is only a preferred embodiment of the present invention, and does not limit the patent scope of the present invention. All equivalent structural changes made by using the contents of the present invention specification under the inventive concept of the present invention, or directly / indirectly applied in other related technical fields are included in the patent protection scope of the present invention.

Claims

1. A method for preparing a brain peptide for preventing Alzheimer's disease, It is characterized in that The following steps are involved: S10. Use animal brain tissue as raw material, grind it at 0-4℃, refrigerate it for 12 h-24 h, drain the acid, wash it, and freeze-dry it to obtain brain tissue powder; S20. mixing the brain tissue powder with the NaCl solution and then soaking it in an MRM molecular resonance environment to cause a salting-out reaction, and centrifuging and filtering it. The filter residue is the brain tissue protein, and the filtrate is the brain tissue peptide solution; S30. Brain tissue protein was suspended in phosphate buffer, papain and bromelain were added, and the amount of negative ions generated was 2000 e - / cm 3 ~2500 e - / cm 3 Under the MRM molecular resonance environment, the reaction was carried out in a water bath at 50℃~60℃ for 60min~90min, the enzyme was inactivated, cooled, centrifuged, and the supernatant was collected to obtain the brain tissue protease hydrolysate; S40. Mix the brain tissue peptide solution, brain tissue protease hydrolysate and weak alkaline buffer, add trypsin and chymotrypsin, react in a water bath at 37°C to 40°C for 60 min to 90 min, inactivate the enzyme, cool, ultrafilter, and spray-dry the filtrate to obtain a brain peptide for preventing Alzheimer's disease; Wherein, in step S20, the mass proportion of NaCl in the NaCl solution is 2%-4%, and the mass concentration of the brain tissue powder in the NaCl solution is 50-70 g / L.

2. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S10, a Tris-HCl buffer solution is used for washing, and the pH value of the Tris-HCl buffer solution is 7.5-8.

5.

3. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S30, the pH value of the phosphate buffer is 6.5-7.

5.

4. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S30, the mass concentration of papain in the phosphate buffer is 40-60 g / L, and the mass concentration of bromelain in the phosphate buffer is 40-60 g / L.

5. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S40, the weak alkaline buffer includes a Tris-HCl buffer, and the pH value of the Tris-HCl buffer is 7.5-8.

5.

6. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S40, the volume ratio of the brain tissue peptide solution, the brain tissue protease hydrolysate and the buffer solution is 1:1:(1-2).

7. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S30, the step of inactivating the enzyme comprises boiling water bath for 10 to 15 minutes; and / or, In step S40, the step of inactivating the enzyme includes boiling water bath for 10 to 15 minutes.

8. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S40, the ultrafiltration step uses a 4.5 kDa ultrafiltration membrane to perform centrifugal filtration separation.

9. The method for preparing the brain peptide for preventing Alzheimer's disease according to claim 1, It is characterized in that In step S40, the step of concentrating and drying includes vacuum freeze drying.